The shipping giant beat on the top-line beat, but missed profit forecasts by four cents, while also cutting its full-year adjusted profit view below estimates.
After abandoning its bid for rival AstraZeneca, Pfizer posted higher-than-expected revenue boosted by cancer-drug demand.
Equity futures edged higher following better-than-expected quarterly results from Pfizer and Merck, and ahead of home prices and consumer data.
Tuesday starting at 9a ET: Investing overseas! Maria gets expert insight on where to put your money around the world! Plus, Mike Huckabee reacts to the latest proposal to legalize pot!
Tuesday at 7p ET: Executive action or overreaction? One lawmaker breaks down the border plan and how to make sense of Obama’s immigration threats!